Skip to main content
Erschienen in: BMC Infectious Diseases 1/2018

Open Access 01.12.2018 | Case report

Enterococcus gallinarum meningitis: a case report and literature review

verfasst von: Bo Zhao, Mao Sheng Ye, Rui Zheng

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2018

Abstract

Background

As an opportunistic pathogen, E. gallinarum mainly leads to nosocomial infections, and it’s multi-drug resistance has gained more and more attention. Central nervous system infections caused by E. gallinarum are rare, but have been reported more often in recent years. The previous cases were generally secondary to neurosurgery, especially ventriculoperitoneal shunts. In recent years, the cases largely occurred in patients with impaired immune function. The patient in our report may have had dual risk factors (immune impairment and an invasive surgical procedure).

Case presentation

The patient, a 35-year-old female, was admitted to our hospital for headaches of 3 days duration accompanied by nausea and vomiting for 2 days. The patient had fevers and chills for 3 days before admission; the peak body temperature was 38.5 °C. The patient had a splenectomy in our hospital 2 years earlier for thrombocytopenia and was thought to be immunocompromised. The abnormal findings on physical examination and laboratory testing were as follows: neck stiffness, present; lumbar puncture: pressure, 300 mmH2O; Pandy’s test, positive; white blood cell (WBC) count, 1536 × 106/L; monocyte count, 602 × 106/L; monocyte percentage, 39.2%; multinucleate cell count, 934 × 106/L; multinucleate cell percentage, 60.8%; protein, 1.08 g/L; WBC count, 21.1 × 109/ L; neutrophil percentage, 85.3%; neutrophil count, 20.55 × 109/L; C reactive protein (CRP): 136.4 mg/L; procalcitonin, 6.70 ng/mL. The patient was given meropenem (2.0 g, intravenous infusion, every 8 h) for anti-infection supplemented with other symptomatic support treatments. The patient’s fever and headache had no significant relief.

Conclusions

Central nervous system infections caused by E. gallinarum are rare, but should be suspected, particularly inpatients with impaired immune function or ineffective treatment. Avoiding long-term invasive treatment and improving immunity are helpful to reduce the occurrence of E. gallinarum infections. Early detection and diagnosis, as well as rational antibiotic use, are the keys to achieve satisfactory efficacy.
Abkürzungen
BG
Blood glucose
CRP
C reactive protein
CT
Computed tomography
FBG
Fasting blood glucose
i.v.
Intravenous
MIC
Minimal inhibitory concentration
MRA
Magnetic Resonance Angiography
MRI
Magnetic Resonance Imaging
MRV
Magnetic Resonance Venography
R
Resistance
RBC
Red Blood Cell
RBG
Random blood glucose
S
Sensitive
VP shunt
Ventriculoperitoneal shunt
WBC
White blood cell

Background

As an opportunistic pathogen, E. gallinarum mainly leads to nosocomial infections, and it’s multi-drug resistance has gained more and more attention. Central nervous system infections caused by E. gallinarum are rare, but have been reported more often in recent years. The previous cases were generally secondary to neurosurgery, especially ventriculoperitoneal shunts. In recent years, the cases largely occurred in patients with impaired immune function. The patient in our report may have had dual risk factors (immune impairment and an invasive surgical procedure).

Case presentation

The patient, a 35-year-old female, was admitted to our hospital for evaluation of headaches of 3 days duration accompanied by nausea and vomiting for 2 days. The patient had fevers and chills for 3 days before admission; the peak body temperature was 38.5 °C. 2 days before admission, the patient developed headaches, which were persistent and intolerable, accompanied by four episodes of vomiting. The patient had a splenectomy in our hospital 2 years earlier for thrombocytopenia and was thought to be immunocompromised. The findings on physical examination, imaging, and laboratory testing after admission were as follows: skin and mucous, normal; heart, lung, and abdomen, normal; neck stiffness, present; Kernig’s sign, negative; lumbar puncture: pressure, 300 mmH2O; Pandy’s test, positive; white blood cell (WBC) count, 1536 × 106/L; monocyte count, 602 × 106/L; monocyte percentage, 39.2%; multinucleate cell count, 934 × 106/L; multinucleate cell percentage, 60.8%; protein, 1.08 g/L (Table 1); head and chest CT, normal; head contrast MRI + MRA + MRV, normal; WBC count, 21.1 × 109/ L; neutrophil percentage, 85.3%; neutrophil count, 20.55 × 109/L; C reactive protein (CRP): 136.4 mg/L; procalcitonin, 6.70 ng/mL; liver and kidney function, normal; and electrolytes, normalMeropenem (2.0 g intravenous infusion every 8 h) was administered with other symptomatic support treatments, such as reducing intracranial pressure by mannitol. The temperature fluctuated around 38 °C. There was no significant relief from the headaches. A lumbar puncture was repeated 6 days after admission. The cerebrospinal fluid culture and drug sensitivity testing showed an Enterococcus gallinarum infection and sensitivity to linezolid (Table 2), respectively. Thus, an intravenous infusion of linezolid (0.6 g every 12 h) was administered. On the second day of linezolid, the temperature began to decrease. After 3 weeks of anti-E. gallinarum treatment, the temperature returned to normal and the headache resolved. A lumbar puncture was repeated three times. The cerebrospinal fluid was colorless and transparent, the pressure and WBC count were decreased, and the bacterial cultures were negative. The patient was discharged from the hospital when stable and in good condition.
Table 1
Results of lumbar puncture after admission
Lumbar puncture
1st day
6th day
14th day
22nd day
31st day
Pressure mmH2O (80–180)
300
300
160
110
110
Appearance (Colorless and transparent)
Colorless and transparent
Light yellow and transparent
Colorless and transparent
Colorless and transparent
Colorless and transparent
Pandy’s test (−)
+
+
Weak positive
Weak positive
WBC count 106/L (0–8)
1536
204
107
36
11
Monocyte count 106/L (not available)
602
164
106
36
10
Monocyte percentage % (not available)
39.2
92.1
99.1
100.0
97.9
Multinucleate cell count 106/L (not available)
934
40
1
0
1
Multinucleate cell percentage % (not available)
60.8
7.9
0.9
0
2.1
RBC count 106/L (0)
0
0
0
0
0
Glucose mmol/L (2.5–4.5)
3.21 (RBG 6.80)
2.32 (BG not tested)
3.33 (FBG 5.71)
3.03 (BG not tested)
3.1 (FBG 4.54)
Chlorine mmol/L (120–132)
121.5
115
120.0
118.2
119.7
Protein g/L (0.15–0.45)
1.08
0.84
0.52
0.41
0.33
Cryptococcus smear (Ink stain)
Mycobacterium tuberculosis smear (Acid-fast stain)
Bacterial smear (Gram’s stain)
Bacterial culture (Plate cultivation)
Enterococcus gallinarum
BG blood glucose, RBG random blood glucose, FBG fasting blood glucose
Table 2
The susceptibility results of E.gallinarum
Antibiotic name
Method
Result
Sensitivity
Determination standard
Sensitive
Intermediary
Resistance
Penicillin G
MIC
8.0
S
≥16
 
≤8
Vancomycin
MIC
2.0
R
≥32
8–16
≤4
Linezolid
MIC
1.0
S
≥8
4
≤2
Tetracycline
MIC
≥16.0
R
≥16
8
≤4
Ciprofloxacin
MIC
≤0.5
S
≥4
2
≤1
Erythromycin
MIC
8.0
R
≥8
1–4
≤0.5
Levofloxacin
MIC
1.0
S
≥8
4
≤2
Ampicllin
MIC
≤2.0
S
≥16
 
≤8
Quinupristin/Dalfopristin
MIC
1.0
R
≥4
2
≤1
Clindamycin
MIC
≥8.0
R
≥4
1–2
≤0.5
Moxifloxacin
MIC
≤0.25
S
≥4
2
≤1
Tigecycline
MIC
≤0.12
S
  
≤0.25
Gentamicin-High
MIC
 
S
   
Streptomycin-High
MIC
 
R
   
MIC minimal inhibitory concentration, R resistance, S sensitive

Discussion and conclusions

Enterococcus gallinarum was first isolated from the gut of a chicken. Enterococcus gallinarum is normal flora in human and animal guts [1]. In recent years, with the increasing use of broad-spectrum antibiotics and invasive medical devices, infections caused by E. gallinarum have gradually increased, and multi-drug resistance has gained more and more attention. In 2010, among the isolated strains of Enterococcus in several Chinese hospitals, E. gallinarum accounted for 1.9% of isolates, and second only to E. faecalis and E. faecium [2]. As an opportunistic pathogen, E. gallinarum mainly leads to nosocomial infections, including urinary tract, abdominal, biliary tract, and a small percentage of bloodstream infections. Patients who undergo invasive operations or are immunosuppressed are susceptible [3, 4]. Central nervous system infections caused by E. gallinarum are rare, but have been reported more often in recent years.
Symptoms of E. meningitis include fevers and headaches, which may be accompanied by a disturbance of consciousness or even convulsions. Some patients may have septic shock, focal neurologic deficits, petechial rashes, and meningeal irritation [4]. High value of CRP and procalcitonin can be found in patients with E. gallinarum meningitis. The diagnosis of E. gallinarum meningitis is based on clinical symptoms, cerebrospinal fluid examination, and pathogen culture. PCR is also used for diagnosis, the results of which can be obtained 48 h earlier than routine bacterial cultures [5]. The patient in this report exhibited fevers, headaches, and neck stiffness. The cerebrospinal fluid was purulent and the culture confirmed an infection with E. gallinarum. The patient had undergone a splenectomy and her immunoglobulin level was lower than the normal value, suggesting impairment of humoral immune function, which increased her risk for opportunistic infections [6]. The cerebrospinal fluid culture after the first lumbar puncture was negative, and the possibility that the pathogen was introduced by the first lumbar puncture could not be excluded. Moreover, the administration of broad-spectrum antibiotics may have exacerbated the infection.
There have been eight E. gallinarum meningitis cases reported worldwide (Table 3). The previous cases were generally secondary to neurosurgery, especially ventriculoperitoneal shunts. In recent years, the cases largely occurred in patients with impaired immune function. The patient in our report may have had dual risk factors (immune impairment and an invasive surgical procedure).
Table 3
Enterococcus gallinarum meningitis reports in the literature
Reference
Country
Gender
Age
Symptoms
Susceptibility factors
Treatment
Outcome
Yoko Takayama, et al. [8] 2003
Japan
Male
57 years
Fever
Neck stiffness
VP shunt for subarachnoid hemorrhage
Rheumatoid arthritis with prednisolone and anti-rheumatic drugs
i.v. teicoplanin for 4 weeks
VP shunt removal
Cured
Yoko Takayama. et al. [8] 2003
Japan
Male
12 years
Fever
Drowsy
Limb cramps
VP shunt for astrocytoma
i.v. ampicillin for 8 weeks
VP shunt replaced
Cured
Asok Kurup, et al. [9] 2001
Singapore
Male
64 years
Fever
Drowsy
VP shunt for multi-loculated hydrocephalus
i.v. ampicillin and gentamicin for 3 weeks
Cured
Fahmi Yousef Khan, et al. [10] 2011
Pakistan
Female
53 years
Fever
Headache
Consciousness disturbance
Neck stiffness
Decompression craniotomy for cerebral hemorrhage
i.v. linezolid for 3 weeks
Cured
Vicente Sperb Antonello, et al. [11] 2010
Brazil
Male
53 years
Mental confusion
Fever
Ataxia
Neck stiffness
Alcohol abuse
i.v. ampicillin and gentamycin for 3 weeks
Cured
B. Roca, et al. [12] 2006
Spain
Female
51 years
Fever
Headache
Cerebrospinal fluid drainage catheter for persistent right nostril rhinorrhea
i.v. ampicillin and rifampin for 3 weeks
Drain removal
Cured
Po-Yi Paul Su, et al. [5] 2016
USA
Male
53 years
Fever
Neck stiffness
Acute lymphoblastic B cell leukemia with chemotherapy
Neutropenic
Broad-spectrum antibiotics usage
Type 2 diabetes mellitus
i.v. ampicillin and ceftriaxone for 4 weeks
Cured
Quanxiao Li, et al. [13] 2013
China
Male
2 days
Fever
Hypermyotonia
Neonatal hemolysis
i.v. linezolid for 3 weeks
Cured
VP shunt ventriculoperitoneal shunt, i.v intravenous
Enterococcus gallinarum carries the vanC drug-resistance gene and has a high rate of resistance for vancomycin (82.1%). The pathogen is relatively sensitive to teicoplanin and linezolid [2]. The strains carrying the vanA or vanB resistance genes have been isolated, and are resistant to vancomycin and teicoplanin.[7]. Based on drug sensitivity testing, we chose linezolid at an adequate dose and time to treat the patient. The course of linezolid generally lasts 3 weeks or longer, and the prognosis is good. We recommended a 3-week course of linezolid and obtained satisfactory efficacy. The symptoms, signs, and follow-up results of the cerebrospinal fluid were all remarkably improved after treatment. The patient did not relapse after treatment was completed.
Avoiding long-term invasive treatment and improving immunity are helpful to reduce the occurrence of E. gallinarum infections. Early detection and diagnosis, as well as rational antibiotic use, are the keys to achieve satisfactory efficacy.

Availability of data and materials

All the data supporting our findings is contained within the manuscript.
Not Applicable.
The patient gave a written consent for publication of her potentially identifying information.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Oladipo IC, Sanni AI, Writachit C, Chakravorty S, Jana S, Rudra DS, et al. Bioprotective potential of bacteriocinogenic enterococcus gallinarum strains isolated from some Nigerian fermented foods, and of their bacteriocins. Pol J Microbiol. 2014;63(4):415–22.PubMed Oladipo IC, Sanni AI, Writachit C, Chakravorty S, Jana S, Rudra DS, et al. Bioprotective potential of bacteriocinogenic enterococcus gallinarum strains isolated from some Nigerian fermented foods, and of their bacteriocins. Pol J Microbiol. 2014;63(4):415–22.PubMed
2.
Zurück zum Zitat Yang Qing YY, Yuxing NI. CHINET 2010 surveillance of antibiotic resistance in enterococcus in China. Chin J Infect Chemother. 2012;12(2):92–7. Yang Qing YY, Yuxing NI. CHINET 2010 surveillance of antibiotic resistance in enterococcus in China. Chin J Infect Chemother. 2012;12(2):92–7.
3.
Zurück zum Zitat HOU Hui-ling NX-h. Analysis of clinical characteristic and drug resistance of infected cases due to enterococcus gallinarum (a 35-case report). J Clin Pulm Med. 2010;15(3):308–9. HOU Hui-ling NX-h. Analysis of clinical characteristic and drug resistance of infected cases due to enterococcus gallinarum (a 35-case report). J Clin Pulm Med. 2010;15(3):308–9.
4.
Zurück zum Zitat O'Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8:217–30.PubMedPubMedCentral O'Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8:217–30.PubMedPubMedCentral
5.
Zurück zum Zitat Su PY, Miller S, Rutishauser RL, Babik J. Broad-range PCR for early diagnosis of nosocomial enterococcus gallinarum meningitis. Infect Dis (Lond). 2016;48(8):640–2.CrossRef Su PY, Miller S, Rutishauser RL, Babik J. Broad-range PCR for early diagnosis of nosocomial enterococcus gallinarum meningitis. Infect Dis (Lond). 2016;48(8):640–2.CrossRef
6.
Zurück zum Zitat Japanese Respiratory Society. Pneumonia in immunocompromised patients. Respirology. 2009;14(Suppl 2):S44–50. Japanese Respiratory Society. Pneumonia in immunocompromised patients. Respirology. 2009;14(Suppl 2):S44–50.
7.
Zurück zum Zitat Eshaghi A, Shahinas D, Li A, Kariyawasam R, Banh P, Desjardins M, et al. Characterization of an enterococcus gallinarum isolate carrying a dual vanA and vanB cassette. J Clin Microbiol. 2015;53(7):2225–9.CrossRefPubMedPubMedCentral Eshaghi A, Shahinas D, Li A, Kariyawasam R, Banh P, Desjardins M, et al. Characterization of an enterococcus gallinarum isolate carrying a dual vanA and vanB cassette. J Clin Microbiol. 2015;53(7):2225–9.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Takayama Y, Sunakawa K, Akahoshi T. Meningitis caused by enterococcus gallinarum in patients with ventriculoperitoneal shunts. J Infect Chemother. 2003;9(4):348–50.CrossRefPubMed Takayama Y, Sunakawa K, Akahoshi T. Meningitis caused by enterococcus gallinarum in patients with ventriculoperitoneal shunts. J Infect Chemother. 2003;9(4):348–50.CrossRefPubMed
9.
Zurück zum Zitat Kurup A, Tee WS, Loo LH, Lin R. Infection of central nervous system by motile enterococcus: first case report. J Clin Microbiol. 2001;39(2):820–2.CrossRefPubMedPubMedCentral Kurup A, Tee WS, Loo LH, Lin R. Infection of central nervous system by motile enterococcus: first case report. J Clin Microbiol. 2001;39(2):820–2.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Khan FY, Elshafi SS. Enterococcus gallinarum meningitis: a case report and literature review. J Infect Dev Ctries. 2011;5(3):231–4.CrossRefPubMed Khan FY, Elshafi SS. Enterococcus gallinarum meningitis: a case report and literature review. J Infect Dev Ctries. 2011;5(3):231–4.CrossRefPubMed
11.
Zurück zum Zitat Antonello VS, Zenkner Fde M, Franca J, Santos BR. Enterococcus gallinarum meningitis in an immunocompetent host: a case report. Rev Inst Med Trop Sao Paulo. 2010;52(2):111–2.CrossRefPubMed Antonello VS, Zenkner Fde M, Franca J, Santos BR. Enterococcus gallinarum meningitis in an immunocompetent host: a case report. Rev Inst Med Trop Sao Paulo. 2010;52(2):111–2.CrossRefPubMed
12.
Zurück zum Zitat Roca B, Pesudo JV, Gonzalez-Darder JM. Meningitis caused by enterococcus gallinarum after lumbar drainage of cerebrospinal fluid. Eur J Intern Med. 2006;17(4):298–9.CrossRefPubMed Roca B, Pesudo JV, Gonzalez-Darder JM. Meningitis caused by enterococcus gallinarum after lumbar drainage of cerebrospinal fluid. Eur J Intern Med. 2006;17(4):298–9.CrossRefPubMed
13.
Zurück zum Zitat Li XQ, Fan SJ, Liu L, Xiao M, Lin XJ. Enterococcus gallinarum meningitis: a case report. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15(12):1096–7.PubMed Li XQ, Fan SJ, Liu L, Xiao M, Lin XJ. Enterococcus gallinarum meningitis: a case report. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15(12):1096–7.PubMed
Metadaten
Titel
Enterococcus gallinarum meningitis: a case report and literature review
verfasst von
Bo Zhao
Mao Sheng Ye
Rui Zheng
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2018
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3151-4

Weitere Artikel der Ausgabe 1/2018

BMC Infectious Diseases 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.